Scientists have developed new gene delivery tools that can target and activate specific cell types in the brain and spinal cord, offering promising potential for targeted treatments of neurodegenerative diseases like ALS, Parkinson's, and Alzheimer's, as part of the NIH BRAIN initiative.
Scientists have developed a programmable system for protein delivery into cells by re-engineering an injection system found in bacteria. The system can be customized to target specific cells and deliver customized protein cargoes, offering potential for biomedical applications. The re-engineered injection complexes represent an exciting biotechnological toolbox that could have applications in various biological systems.